B&K CORP-B (02396) announced its financial results for the year ended December 31, 2025. The group recorded revenue of 522,000 yuan, representing a 100% increase compared to the previous year. The annual net loss was 209 million yuan, a decrease of 1.5% year-on-year. Loss per share was 2.08 yuan.
According to the announcement, the growth in revenue was primarily due to a one-time sale of PDGF BB reagents for research and experimental purposes to a single customer. The provision of research services and the sale of PDGF-BB reagents are not part of the company's core business operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments